top of page
Publications
Explore scientific publications and media articles showcasing our research and scientific achievements
-
Telomir-Zn Shows Therapeutic Potential in Wilson’s Disease Research
New research demonstrates that Telomir-Zn reduces copper-induced oxidative stress, improves locomotor function, lowers hepatic copper accumulation, and prolongs survival in a Wilson’s disease zebrafish model — highlighting intracellular metal modulation as a promising complementary therapeutic approach.
(January 2026)
-
Breakthrough Collaboration with Telomir Pharmaceuticals
Telomir-1 Shows Significant Potential in Restoring Cellular Health and Advancing Alzheimer’s and Parkinson’s Research.
(July 2025)
-
Telomir-1 Prevents Cellular Aging in Progeria Patient-Derived Cells
(June 2025)
In Joint effort, Smart Assays and Telomir Pharmaceuticals show that Telomir-1 prevents cellular aging in patient-derived cells from children with Progeria, unlocking insights into ultra-rare genetic disorders.
-
Magnolol's Potential to Enhance Skin Volume and vitality
(April 2025)
In Collaboration with Galderma, Smart Assays Uncovers Magnolol’s Unique Potential to Support Skin Volume and Vitality Through Adipogenic Activity.
-
Telomir-1's Copper-Binding Ability Supports Wilson's Disease Research
(December 2024)
In Joint Research with Telomir Pharmaceuticals, Smart Assays Confirms Telomir-1’s Copper-Binding Ability, Advancing Wilson’s Disease Research and Development.
-
Taffix® Nasal Powder Spray Forms a Protective Barrier Against SARS- CoV-2 Variants
(October 2021)
Smart Assays demonstrates that Taffix nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2, including Alpha, Beta and Delta.
bottom of page